Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Instagram Outage Disrupts Thousands of U.S. Users 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
LOS ANGELES, Calif., Dec. 19, 2017 -- Strategic Directions International (SDi), a division of BioInformatics LLC, announced today the 2018 Global Assessment Report: The Laboratory Analytical & Life Science Instrumentation Industry will be released in conjunction with PITTCON, which will take place from February 26 - March 1, 2018. The report is widely considered to be the gold standard of market intelligence for the $50+ billion laboratory market for analytical and life science instruments. The report can be pre-purchased at a significant discount as part of the Company’s 2018 subscription plan.
The report will update projections made in 2017 where market conditions have contributed to growth or contraction. As in the past, detailed information on 82 different product categories is presented in 10 sections that include chromatography, life science instrumentation, mass spectrometry, molecular spectroscopy, atomic spectroscopy, surface science, materials characterization, lab automation, general analytical techniques, and lab equipment.
For this first time, users of the report will have an option to receive an electronic data stream updating the market projections on a quarterly basis.
The announcement was made at the unveiling of the combined SDi/BioInformatics market intelligence portfolio of reports for 2018 that includes 15 titles on both emerging and established markets and the Global Assessment report quarterly data stream. Heavily discounted prices are available for companies that subscribe before year’s end. Corporate subscribers will also receive unlimited access to all market research reports published in the last five years by both SDi and BioInformatics.
ABOUT IBO and BIOINFORMATICS LLC
Strategic Directions International (SDi), a leading international management-consulting firm in the highly specialized field of analytical instruments, was acquired by BioInformatics LLC in 2014. The two firms combined to form the premier research and advisory firm serving the life science and analytical instrument industry. Our expertise includes assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customers’ brand loyalty, and evaluating brand strength and positioning, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.
www.gene2drug.com
For more information contact: Mike Tice Vice President of Markets & Strategy Strategic Directions International A division of BioInformatics LLC 6242 Westchester Parkway, Suite 100 Los Angeles, CA 90045-4820 United States Phone: 310.641.4982 [email protected] www.gene2drug.com
